0.70 (-%)
As of Nov 21, 2024
Source:
bioAffinity Technologies, Inc. develops noninvasive, early-stage diagnostics to detect and researches targeted therapies to detect and treat lung cancer and other diseases of the lung at the cellular level.
Country | United States |
Headquarters | san antonio, texas |
Phone Number | 210-698-5334 |
Industry | |
CEO | Maria Zannes |
Website | www.bioaffinitytech.com |